Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia [Short Communication]

Authors: Riekstina, V.¹; Leimane, V.¹; Holtz, T.H.²; Leimans, J.¹; Wells, C.D.²

Source: The International Journal of Tuberculosis and Lung Disease, Volume 11, Number 5, May 2007 , pp. 585-587(3)

Publisher: International Union Against Tuberculosis and Lung Disease

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 months after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

Keywords: tuberculosis; multidrug-resistant tuberculosis; treatment outcomes; cohort analysis

Document Type: Short communication

Affiliations: 1: State Agency for Tuberculosis and Lung Diseases, Riga, Latvia 2: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Free content The full text is free.

View now: